Promising Immunotherapy Agents for NSCLC – OncLive
OncLive |
Promising Immunotherapy Agents for NSCLC
OncLive Everett Vokes, MD: Roy, I'd like to turn to you, again, a little bit, as somebody who's been involved in investigational therapies throughout your career. What are new, promising single agents (immunotherapy agents), and what combinations excite you as … |
